11/18/2024
4:26 PM | Neurogene Inc. (Filer)
Neurogene Inc. (Filer)
Neurogene (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/18/2024
4:27 PM | Neurogene Inc. (Filer)
Neurogene Inc. (Filer)
Neurogene (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
11/18/2024
5:50 AM | Neurogene Inc. (Filer)
Neurogene Inc. (Filer)
Neurogene (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/14/2024
3:53 PM | GREAT POINT PARTNERS LLC (Filed by)
Neurogene Inc. (Subject)
Neurogene Inc. (Subject)
Neurogene (Subject)
| Form SC 13G/A | |
11/14/2024
2:24 PM | JANUS HENDERSON GROUP PLC (Filed by)
Neurogene Inc. (Subject)
Neurogene Inc. (Subject)
Neurogene (Subject)
| Form SC 13G/A | |
11/14/2024
2:05 PM | Cormorant Asset Management, LP (Filed by)
Neurogene Inc. (Subject)
Neurogene Inc. (Subject)
Neurogene (Subject)
| Form SC 13G/A | |
11/14/2024
5:22 AM | Neurogene Inc. (Subject)
Neurogene Inc. (Subject)
Neurogene (Subject)
RTW INVESTMENTS, LP (Filed by)
| Form SC 13G | |
|
11/04/2024
6:33 AM | Neurogene Inc. (Filer)
Neurogene Inc. (Filer)
Neurogene (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/09/2024
3:15 PM | Neurogene Inc. (Filer)
Neurogene Inc. (Filer)
Neurogene (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
08/09/2024
6:31 AM | Neurogene Inc. (Filer)
Neurogene Inc. (Filer)
Neurogene (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/07/2024
6:31 AM | Neurogene Inc. (Filer)
Neurogene Inc. (Filer)
Neurogene (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/08/2024
3:36 PM | BlackRock Inc. (Filed by)
Neurogene Inc. (Subject)
Neurogene Inc. (Subject)
Neurogene (Subject)
| Form SC 13G | |
06/21/2024
7:32 AM | Neurogene Inc. (Filer)
Neurogene Inc. (Filer)
Neurogene (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/18/2024
1:11 PM | Neurogene Inc. (Filer)
Neurogene Inc. (Filer)
Neurogene (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/17/2024
1:35 PM | Neurogene Inc. (Filer)
Neurogene Inc. (Filer)
Neurogene (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/17/2024
1:35 PM | Freedland Cory S. (Reporting)
Neurogene Inc. (Issuer)
Neurogene Inc. (Issuer)
Neurogene (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/17/2024
1:36 PM | Neurogene Inc. (Issuer)
Neurogene Inc. (Issuer)
Neurogene (Issuer)
Noonberg Sarah B. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/17/2024
1:36 PM | BAFFI ROBERT (Reporting)
Neurogene Inc. (Issuer)
Neurogene Inc. (Issuer)
Neurogene (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/17/2024
1:37 PM | Neurogene Inc. (Issuer)
Neurogene Inc. (Issuer)
Neurogene (Issuer)
PALEKAR ROHAN (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/17/2024
1:37 PM | Neurogene Inc. (Issuer)
Neurogene Inc. (Issuer)
Neurogene (Issuer)
Woods Robert Keith (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/03/2024
6:31 AM | Neurogene Inc. (Filer)
Neurogene Inc. (Filer)
Neurogene (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/10/2024
6:31 AM | Neurogene Inc. (Filer)
Neurogene Inc. (Filer)
Neurogene (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/07/2024
5:20 AM | Neurogene Inc. (Filer)
Neurogene Inc. (Filer)
Neurogene (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/26/2024
1:33 PM | Neurogene Inc. (Filer)
Neurogene Inc. (Filer)
Neurogene (Filer)
| Form DEF 14A | |
04/26/2024
1:33 PM | Neurogene Inc. (Filer)
Neurogene Inc. (Filer)
Neurogene (Filer)
| Form ARS | |
04/26/2024
1:34 PM | Neurogene Inc. (Filer)
Neurogene Inc. (Filer)
Neurogene (Filer)
| Form DEFA14A | |
04/22/2024
3:44 PM | Neurogene Inc. (Filer)
Neurogene Inc. (Filer)
Neurogene (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/02/2024
2:43 PM | Neurogene Inc. (Filer)
Neurogene Inc. (Filer)
Neurogene (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/14/2024
7:51 PM | Cobb Stuart (Reporting)
Neurogene Inc. (Issuer)
Neurogene Inc. (Issuer)
Neurogene (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/14/2024
7:53 PM | Cvijic Christine Mikail (Reporting)
Neurogene Inc. (Issuer)
Neurogene Inc. (Issuer)
Neurogene (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/14/2024
7:54 PM | McMinn Rachel (Reporting)
Neurogene Inc. (Issuer)
Neurogene Inc. (Issuer)
Neurogene (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/07/2024
3:29 PM | Babler Martin (Reporting)
Neurogene Inc. (Subject)
Neurogene Inc. (Subject)
Neurogene (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
03/04/2024
5:20 PM | Neurogene Inc. (Subject)
Neurogene Inc. (Subject)
Neurogene (Subject)
Smith Sean Michael (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
03/04/2024
6:30 AM | Neurogene Inc. (Filer)
Neurogene Inc. (Filer)
Neurogene (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/20/2024
3:16 PM | Neurogene Inc. (Filer)
Neurogene Inc. (Filer)
Neurogene (Filer)
| Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
02/14/2024
5:05 PM | EcoR1 Capital, LLC (Filed by)
Neurogene Inc. (Subject)
Neurogene Inc. (Subject)
Neurogene (Subject)
| Form SC 13G | |
02/14/2024
8:19 AM | Lynx1 Capital Management LP (Filed by)
Neurogene Inc. (Subject)
Neurogene Inc. (Subject)
Neurogene (Subject)
| Form SC 13G/A | |
02/09/2024
3:35 PM | Neurogene Inc. (Subject)
Neurogene Inc. (Subject)
Neurogene (Subject)
SIMPSON TODD E (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
01/18/2024
5:56 PM | Neurogene Inc. (Issuer)
Neurogene Inc. (Issuer)
Neurogene (Issuer)
Noonberg Sarah B. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/18/2024
5:58 PM | Neurogene Inc. (Issuer)
Neurogene Inc. (Issuer)
Neurogene (Issuer)
PALEKAR ROHAN (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/18/2024
6:01 PM | Neurogene Inc. (Issuer)
Neurogene Inc. (Issuer)
Neurogene (Issuer)
Woods Robert Keith (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
Download Our Tesla Ebook For Free (Ad) Like many of you, we here at the TradingPub are bullish on Tesla long term.
We believe the company will continue to be a leader in technology, EVs and A.I.
We also believe it’s share price will be rewarded in a big way…
In fact, our #1 Tesla expert just published a brand new Ebook regarding Tesla’s future, and we’d like to send it to you at no cost. To claim your copy free of charge simply follow this link. |
01/18/2024
5:45 PM | Jordan Julie (Reporting)
Neurogene Inc. (Issuer)
Neurogene Inc. (Issuer)
Neurogene (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
01/18/2024
5:48 PM | Jordan Julie (Reporting)
Neurogene Inc. (Issuer)
Neurogene Inc. (Issuer)
Neurogene (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/18/2024
5:51 PM | BAFFI ROBERT (Reporting)
Neurogene Inc. (Issuer)
Neurogene Inc. (Issuer)
Neurogene (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/18/2024
5:53 PM | Freedland Cory S. (Reporting)
Neurogene Inc. (Issuer)
Neurogene Inc. (Issuer)
Neurogene (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/05/2024
6:11 AM | Neurogene Inc. (Filer)
Neurogene Inc. (Filer)
Neurogene (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/26/2023
5:04 PM | Freedland Cory S. (Reporting)
Neurogene Inc. (Issuer)
Neurogene Inc. (Issuer)
Neurogene (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
12/26/2023
5:05 PM | Cobb Stuart (Reporting)
Neurogene Inc. (Issuer)
Neurogene Inc. (Issuer)
Neurogene (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
12/26/2023
5:10 PM | BAFFI ROBERT (Reporting)
Neurogene Inc. (Issuer)
Neurogene Inc. (Issuer)
Neurogene (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
12/26/2023
5:10 PM | Neurogene Inc. (Issuer)
Neurogene Inc. (Issuer)
Neurogene (Issuer)
Woods Robert Keith (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
12/26/2023
5:12 PM | McMinn Rachel (Reporting)
Neurogene Inc. (Issuer)
Neurogene Inc. (Issuer)
Neurogene (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
12/26/2023
5:16 PM | Cvijic Christine Mikail (Reporting)
Neurogene Inc. (Issuer)
Neurogene Inc. (Issuer)
Neurogene (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
12/20/2023
5:43 PM | 667, L.P. (Reporting)
Baker Bros. Advisors LLC (0001580575) (Reporting)
BAKER BROS. ADVISORS LP (Reporting)
Baker Brothers Life Sciences LP (Reporting)
BAKER FELIX (Reporting)
BAKER JULIAN (Reporting)
Neurogene Inc. (Issuer)
Neurogene Inc. (Issuer)
Neurogene (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/20/2023
4:24 PM | BAKER BROS. ADVISORS LP (Filed by)
Neurogene Inc. (Subject)
Neurogene Inc. (Subject)
Neurogene (Subject)
| Form SC 13D/A | |
12/19/2023
6:31 AM | Neurogene Inc. (Filer)
Neurogene Inc. (Filer)
Neurogene (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/06/2023
3:21 PM | Neoleukin Therapeutics, Inc. (Filer)
Neoleukin Therapeutics, Inc. (Filer)
Neurogene (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/06/2023
3:24 PM | Neoleukin Therapeutics, Inc. (Subject)
Neoleukin Therapeutics, Inc. (Subject)
Neurogene (Subject)
| Form 425 | |
12/04/2023
4:10 PM | Neoleukin Therapeutics, Inc. (Filer)
Neoleukin Therapeutics, Inc. (Filer)
Neurogene (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/04/2023
4:14 PM | Neoleukin Therapeutics, Inc. (Subject)
Neoleukin Therapeutics, Inc. (Subject)
Neurogene (Subject)
| Form 425 | |
Free NGNE Stock Alerts